The reporter learned from the Provincial Food and Drug Administration on July 30 that in response to 14 kinds of complaints and reports such as Longrun Shengli Capsule and Wang Mazi Tianma Wind Chasing Cream, which are more concentrated and not corrected by many announcements, the food and drug administration department of our province has taken measures such as ordering the removal of shelves and suspending sales.
The names indicated in the 14 kinds of medicinal devices involving enterprises and advertisements are: Longrun Shengli Capsule of Yunnan Longrun Pharmaceutical Co., Ltd.; Wang Mazi Tianma Chasing Wind Cream of Heilongjiang Quanji Pharmaceutical Co., Ltd.; Professor Yang Xuelian Cordyceps Mixture of Chengdu Tianyin Pharmaceutical Co., Ltd.; Yushengtang Imperial Court Qiangyang Bao Kidney Pill of Beijing Yushengtang Group Shijiazhuang Pharmaceutical Co., Ltd.; Kangshou Pill of Guangzhou Baiyunshan Jingxiutang Pharmaceutical Co., Ltd.; and Talking about Bone Talk Health of Ningbo Dahongying Pharmaceutical Co., Ltd. - Elderly Deer Pill Tongbaer brand bone-penetrating bone spirit rubber paste of Inner Mongolia Horqin Pharmaceutical Co., Ltd.; Li Futang Quanlu Pill of Jilin Lisheng Pharmaceutical Co., Ltd.; Huanghua Rhododendron Oil Gum Pill of Qinghai Baojiantang Sinopharm Co., Ltd.; Ginseng Moth Warm Kidney Oral Liquid of Jilin Jinquan Baoshan Pharmaceutical Group Co., Ltd.; Bai ringworm Xia Ta Heat Capsule of Shaanxi Dongtai Pharmaceutical Co., Ltd.; Sanwei Pillow of Jingmen Millennium Healthcare Technology Co., Ltd.; And Left One-handed Bone Cell Repair Solution of Shanghai Taihao Biotechnology (Zhoukou) Pharmaceutical Co., Ltd Nanyang Liangzhiyuan Biotechnology Co., Ltd. far infrared sticker.
The Provincial Food and Drug Administration requires that the local food and drug administration departments notify the drug trading enterprises within their jurisdiction and order them to remove the drugs and devices involved and suspend sales; the regulatory departments will conduct key inspections of the pharmacies involved in the case, conduct sampling inspections of the drugs and devices suspected of quality problems, and if counterfeit and inferior drugs and devices are found, they will be punished in accordance with relevant regulations.